Arcutis Biotherapeutics will present its latest financial results and clinical developments at the TD Cowen 46th Annual Health Care Conference, scheduled for March 2-4, 2026, in Boston. The presentation will provide investors and healthcare professionals with an update on the company's pipeline and business operations following the release of its fourth quarter and full-year 2025 financial results.
The company's attendance at the conference comes as it advances its dermatology-focused product portfolio. Arcutis is also expanding its patient education initiatives, recently launching its "Free to Be Me" awareness campaign in partnership with professional golfer Max Homa to increase recognition of seborrheic dermatitis treatment options among affected patients and healthcare providers.
The TD Cowen conference represents a key opportunity for the biopharmaceutical company to engage with institutional investors and industry stakeholders regarding its strategic priorities and commercial developments.